2014
DOI: 10.1016/j.bbrc.2014.03.149
|View full text |Cite
|
Sign up to set email alerts
|

Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
28
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(32 citation statements)
references
References 28 publications
2
28
0
Order By: Relevance
“…Among the TF only the NR3C2 (mineralocorticoid receptor) was estimated by IPA to be induced during osteogenesis. The NR3C2 has been previously reported to be involved in osteoblast differentiation [ 88 ] but very recently it has been demonstrated to have a negative effect on bone formation by the same nuclear receptor [ 89 ]. SREBP2 is a master regulator of cholesterol synthesis [ 90 ] and the inhibition of this TF supported the inhibition of sterol synthesis indicated by the DIA analysis ( Fig 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Among the TF only the NR3C2 (mineralocorticoid receptor) was estimated by IPA to be induced during osteogenesis. The NR3C2 has been previously reported to be involved in osteoblast differentiation [ 88 ] but very recently it has been demonstrated to have a negative effect on bone formation by the same nuclear receptor [ 89 ]. SREBP2 is a master regulator of cholesterol synthesis [ 90 ] and the inhibition of this TF supported the inhibition of sterol synthesis indicated by the DIA analysis ( Fig 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…It is interesting to note that the recent genome wide association study, aimed at identifying new candidate genes for bone strength, showed a strong association between phenotypes of bone strength and genes belonging to the mineralocorticoid pathway (10). In this regard, it should be mentioned that the expression of mineralocorticoid receptors on bone cells (11,12) could actually suggest a still unknown direct effect of mineralocorticoids on the skeletal tissue. Indeed, in an animal model, Fumoto et al showed that pharmacological inhibition of mineralocorticoid function with eplerenone resulted in increased bone mass, with stimulation of bone formation and suppression of resorption (12).…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, it should be mentioned that the expression of mineralocorticoid receptors on bone cells (11,12) could actually suggest a still unknown direct effect of mineralocorticoids on the skeletal tissue. Indeed, in an animal model, Fumoto et al showed that pharmacological inhibition of mineralocorticoid function with eplerenone resulted in increased bone mass, with stimulation of bone formation and suppression of resorption (12). The treatment with eplerenone as well as the specific deletion of mineralocorticoid receptor in osteocytes improved the cortical bone thinning in the prednisolonetreated mouse (12).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations